Certified by Founder Lodge
Deerfield Management
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $24,000,000
47 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We seek to advance healthcare through investment, information and philanthropy. At Deerfield, we owe our success to our team-oriented process, which brings together many decades of experience
| Company | Date | Round | Raised |
|---|---|---|---|
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
 Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
 Epic Sciences |
April, 17 ,2023 | Unknown | $24,000,000 |
 Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
 Actio Biosciences, Inc. |
September, 15 ,2023 | Series A | $55,000,000 |
 Vesta Healthcare |
September, 05 ,2024 | Series C | $65,000,000 |
 Cortica |
April, 19 ,2023 | Unknown | $75,000,000 |
 Presidio Medical, Inc. |
June, 27 ,2023 | Series C | $72,000,000 |
 Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
| Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
| Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
| Actio Biosciences, Inc. |
September, 15 ,2023 | Series A | $55,000,000 |
| Ray Therapeutics, Inc. |
May, 17 ,2023 | Series A | $100,000,000 |
 Pleno Inc. |
December, 13 ,2024 | Series B | $25,000,000 |
| Vesta Healthcare |
September, 05 ,2024 | Series C | $65,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
| Presidio Medical, Inc. |
June, 27 ,2023 | Series C | $72,000,000 |
 IntusCare |
January, 21 ,2025 | Unknown | $11,500,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
| Octave (US) |
July, 27 ,2023 | Series B | $30,000,000 |
 Perceive Biotherapeutics, Inc. |
February, 20 ,2025 | Series A | $15,000,000 |
| Actio Biosciences, Inc. |
September, 15 ,2023 | Series A | $55,000,000 |
| Pleno Inc. |
December, 13 ,2024 | Series B | $25,000,000 |
| Vesta Healthcare |
September, 05 ,2024 | Series C | $65,000,000 |
| Adela, Inc. |
September, 26 ,2023 | Unknown | $48,000,000 |
 myLaurel® |
June, 04 ,2025 | Unknown | $12,000,000 |
| IntusCare |
January, 21 ,2025 | Unknown | $11,500,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| Pleno Inc. |
December, 13 ,2024 | Series B | $25,000,000 |
| Cohere Health |
February, 06 ,2024 | Unknown | $50,000,000 |
| IntusCare |
January, 21 ,2025 | Unknown | $11,500,000 |
| Perceive Biotherapeutics, Inc. |
February, 20 ,2025 | Series A | $15,000,000 |
| Perceive Biotherapeutics, Inc. |
February, 20 ,2025 | Series A | $15,000,000 |
| Vesta Healthcare |
September, 05 ,2024 | Series C | $65,000,000 |
| myLaurel® |
June, 04 ,2025 | Unknown | $12,000,000 |
| myLaurel® |
June, 04 ,2025 | Unknown | $12,000,000 |
 Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| Pleno Inc. |
December, 13 ,2024 | Series B | $25,000,000 |
| IntusCare |
January, 21 ,2025 | Unknown | $11,500,000 |
| Perceive Biotherapeutics, Inc. |
February, 20 ,2025 | Series A | $15,000,000 |
| myLaurel® |
June, 04 ,2025 | Unknown | $12,000,000 |
| Axon Therapies Inc. |
September, 26 ,2025 | Unknown | $32,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
